International Biotechnology Trust’s PTC Therapeutics PTCT Stock Holding History

International Biotechnology Trust’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$381K	Hold	17,000	–	–	0.13%	62
2023 Q2	$692K	Sell	17,000 -76,000	-82%	-$3.72M	0.21%	53
2023 Q1	$4.5M	Sell	93,000 -51,000	-35%	-$2.33M	1.26%	29
2022 Q4	$5.49M	Buy	144,000 +123,000	+586%	+$5.11M	1.7%	20
2022 Q3	$1.05M	Buy	21,000 +20,158	+2,394%	+$988K	0.34%	51
2022 Q2	$21K	Sell	842 -410,158	-100%	-$14.4M	0.22%	64
2022 Q1	$617K	Sell	411,000 -38,000	-8%	-$1.46M	0.14%	63
2021 Q4	$17.9M	Hold	449,000	–	–	3.98%	8
2021 Q3	$16.7M	Hold	449,000	–	–	4.03%	9
2021 Q2	$18.9M	Buy	449,000 +41,000	+10%	+$1.76M	5%	7
2021 Q1	$19.3M	Buy	408,000 +75,000	+23%	+$4.45M	5.11%	6
2020 Q4	$20.3M	Buy	333,000 +34,000	+11%	+$2M	5.55%	5
2020 Q3	$14M	Hold	299,000	–	–	4.5%	7
2020 Q2	$15.1M	Buy	299,000 +30,000	+11%	+$1.47M	5.03%	6
2020 Q1	$12M	Buy	269,000 +155,000	+136%	+$7.8M	5.46%	7
2019 Q4	$5.47M	Sell	114,000 -122,000	-52%	-$5.18M	1.97%	17
2019 Q3	$7.98M	Sell	236,000 -23,000	-9%	-$1M	3.69%	9
2019 Q2	$11.6M	Buy	259,000 +18,507	+8%	+$731K	4.32%	7
2019 Q1	$9.05M	Buy	+240,493	New	+$8.07M	3.34%	8

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

International Biotechnology Trust's PTCT Position: Q3 2023 in Review

International Biotechnology Trust held its PTC Therapeutics (PTCT) position steady in Q3 2023 at 17,000 shares worth $381K. The position accounts for 0.13% of the portfolio, ranked #62.

International Biotechnology Trust first reported a position in PTCT in Q1 2019 and has held it in 19 quarters since. The position peaked at $20.3M in Q4 2020. 180 funds tracked by Wall St. Rank hold PTCT as of Q3 2023.

International Biotechnology Trust held 17,000 shares of PTC Therapeutics worth $381K as of Q3 2023.
International Biotechnology Trust left its PTC Therapeutics share count unchanged in Q3 2023.
PTC Therapeutics made up 0.13% of International Biotechnology Trust's portfolio in Q3 2023, its #62 holding.
International Biotechnology Trust first reported a position in PTC Therapeutics in Q1 2019 and has held it in 19 quarters since.
International Biotechnology Trust's PTC Therapeutics position peaked at $20.3M in Q4 2020.
180 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.